Extracellular Vesicles in Diagnostics and Therapeutics
Deadline Dec 11 2018 11:59 PM (EST)
Description

Event Date: February 19, 2019
Deadline to Submit Abstracts: December 11, 2018

The field of extracellular vesicles (EV) research has expanded dramatically in recent years, providing new insights into their critical biological functions as well as their therapeutic and diagnostic applications. A heterogeneous pool of lipid-enclosed vesicles, EVs are associated with a wide variety of cell types and encapsulate molecular cargoes such as miRNAs, mRNAs, proteins and lipids. Once thought of simply as carriers of metabolic waste, we now know that these vesicles perform a wide range of tissue-specific functions and are important for cell-cell communication.

The relative simplicity of EV isolation techniques from non-invasive biofluid sampling, in addition to the wealth of information contained therein, makes EV a promising tool for diagnostics and biomarker discovery. Furthermore, EVs are gaining traction as therapeutics themselves, as a unique drug delivery system for a potentially wide variety of indications.

In this symposium, we will review the most recent advances in EV research and their increasing impact on diagnostics and drug development for cancer, neurodegenerative disease, metabolic disease, and cardiovascular disease.

To register for this event, please visit the main website at: www.nyas.org/EV2019


Apply

Extracellular Vesicles in Diagnostics and Therapeutics


Event Date: February 19, 2019
Deadline to Submit Abstracts: December 11, 2018

The field of extracellular vesicles (EV) research has expanded dramatically in recent years, providing new insights into their critical biological functions as well as their therapeutic and diagnostic applications. A heterogeneous pool of lipid-enclosed vesicles, EVs are associated with a wide variety of cell types and encapsulate molecular cargoes such as miRNAs, mRNAs, proteins and lipids. Once thought of simply as carriers of metabolic waste, we now know that these vesicles perform a wide range of tissue-specific functions and are important for cell-cell communication.

The relative simplicity of EV isolation techniques from non-invasive biofluid sampling, in addition to the wealth of information contained therein, makes EV a promising tool for diagnostics and biomarker discovery. Furthermore, EVs are gaining traction as therapeutics themselves, as a unique drug delivery system for a potentially wide variety of indications.

In this symposium, we will review the most recent advances in EV research and their increasing impact on diagnostics and drug development for cancer, neurodegenerative disease, metabolic disease, and cardiovascular disease.

To register for this event, please visit the main website at: www.nyas.org/EV2019


Apply
Deadline
Dec 11 2018 11:59 PM (EST)